Evidence map›Paper›PMID 29159049›Full record

ArticleNeuroImage. Clinical2018

Pre-treatment EEG signal variability is associated with treatment success in depression.

Natalia Jaworska, Hongye Wang, Dylan M Smith, Pierre Blier, Verner Knott, Andrea B Protzner

Abstract read
In one paragraph

Article in NeuroImage. Clinical, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Classifying Driving Fatigue by Using EEG Signals.Computational intelligence and neuroscience · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Natalia JaworskaInstitute of Mental Health Research, Affiliated With the University of Ottawa, ON, Canada.
Hongye WangDepartment of Psychology, University of Calgary, AB, Canada.
Dylan M SmithCenter for Studies in Behavioral Neurobiology, Concordia University, Montreal, QC, Canada.
Pierre BlierInstitute of Mental Health Research, Affiliated With the University of Ottawa, ON, Canada.
Verner KnottInstitute of Mental Health Research, Affiliated With the University of Ottawa, ON, Canada.
Andrea B ProtznerDepartment of Psychology, University of Calgary, AB, Canada; Hotchkiss Brain Institute, University of Calgary, AB, Canada. Electronic address: protzner@ucalgary.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious work suggests that major depressive disorder (MDD) is associated with disturbances in global connectivity among brain regions, as well as local connectivity within regions. However, the relative importance of these global versus local changes for successful antidepressant treatment is unknown. We used multiscale entropy (MSE), a measure of brain signal variability, to examine how the propensity for local (fine scale MSE) versus global (coarse scale MSE) neural processing measured prior to antidepressant treatment is related to subsequent treatment response.

methodsWe collected resting-state EEG activity during eyes-open and closed conditions from unmedicated individuals with MDD prior to antidepressant pharmacotherapy (N = 36) as well as from non-depressed controls (N = 36). Treatment response was assessed after 12 weeks of treatment using the Montgomery-Åsberg Depression Rating Scale (MADRS), at which time participants with MDD were characterized as either responders (≥ 50% MADRS decrease) or non-responders. MSE was calculated from baseline EEG, and compared between controls, future treatment responders and non-responders. Putative interactions with the well-documented age effect on signal variability (increased reliance on local neural communication with increasing age, indexed by greater finer-scale variability) were assessed.

resultsOnly in responders, we found that reduced MSE at fine temporal scales (especially fronto-centrally) and increased MSE diffusely at coarser temporal scales was related to the magnitude of the antidepressant response. In controls and MDD non-responders, but not MDD responders, there was an increase in MSE with age at fine temporal scales and a decrease in MSE with age at coarse temporal scales.

conclusionOur results suggest that an increased propensity toward global processing, indexed by greater MSE at coarser timescales, at baseline appears to facilitate eventual antidepressant treatment response.

Indexed as

AdultAntidepressive AgentsBrainElectroencephalographyFemaleHumansMajor Depressive DisorderMaleMiddle AgedReproducibility of ResultsSignal Processing, Computer-AssistedYoung AdultAntidepressive AgentsDepressionElectroencephalography (EEG)Multi-scale entropy (MSE)ResponseSignal variabilitySpectral power density (SPD)Treatment

Identifiers

PMID29159049
PMCPMC5683802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.